Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2020-02-13 - Introduced in the Senate, Referred to Senate Commerce Committee [S1650 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2020-02-13	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New Jersey S1650

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New Jersey S1650 currently on file.